tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

APTO Stock Latest News

Aptose Biosciences: Promising Clinical Progress and Strategic Collaborations Justify Buy Rating
RatingsAptose Biosciences: Promising Clinical Progress and Strategic Collaborations Justify Buy Rating
3d ago
APTO
Aptose Biosciences price target raised to $6 from $2 at H.C. Wainwright
PremiumThe Fly
Aptose Biosciences price target raised to $6 from $2 at H.C. Wainwright
3d ago
APTO
Aptose Biosciences Advances AML Therapy and Strengthens Financial Position
PremiumCompany Announcements
Aptose Biosciences Advances AML Therapy and Strengthens Financial Position
3d ago
APTO
Aptose Biosciences reports FY24 EPS ($36.38) vs. ($227.43) last year
PremiumThe Fly
Aptose Biosciences reports FY24 EPS ($36.38) vs. ($227.43) last year
3d ago
APTO
Aptose Biosciences (APTO) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Aptose Biosciences (APTO) Q4 Earnings Cheat Sheet
8d ago
APTO
Aptose Biosciences Regains Nasdaq Bid Price Compliance
PremiumCompany AnnouncementsAptose Biosciences Regains Nasdaq Bid Price Compliance
14d ago
8K
APTO
Aptose Biosciences meets Nasdaq minimum bid price compliance
Premium
The Fly
Aptose Biosciences meets Nasdaq minimum bid price compliance
14d ago
APTO
Aptose Biosciences initiated with a Speculative Buy at Alliance Global Partners
Premium
The Fly
Aptose Biosciences initiated with a Speculative Buy at Alliance Global Partners
1M ago
APTO
Aptose Biosciences trading halted, news pending
PremiumThe Fly
Aptose Biosciences trading halted, news pending
1M ago
APTO
Upcoming Stock Splits This Week (February 24 to February 28) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (February 24 to February 28) – Stay Invested
1M ago
GRI
APTO
Aptose Biosciences Advances TUSCANY Trial Dosage Escalation
PremiumCompany Announcements
Aptose Biosciences Advances TUSCANY Trial Dosage Escalation
1M ago
8K
APTO
Aptose Biosciences approved to escalate dose in Phase 1/2 AML trial
PremiumThe Fly
Aptose Biosciences approved to escalate dose in Phase 1/2 AML trial
1M ago
APTO
Aptose Biosciences Announces Reverse Share Split
PremiumCompany AnnouncementsAptose Biosciences Announces Reverse Share Split
1M ago
8K
APTO
Aptose Biosciences announces 1-for-30 reverse share split
Premium
The Fly
Aptose Biosciences announces 1-for-30 reverse share split
1M ago
APTO
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
XLO
ABBV
Aptose Biosciences Secures $25M Share Purchase Agreement
PremiumCompany Announcements
Aptose Biosciences Secures $25M Share Purchase Agreement
2M ago
8K
APTO
Aptose Biosciences files to sell 12.03M shares of common stock for holders
PremiumThe Fly
Aptose Biosciences files to sell 12.03M shares of common stock for holders
2M ago
APTO
Aptose Biosciences Establishes $25M Equity Facility
PremiumCompany Announcements
Aptose Biosciences Establishes $25M Equity Facility
2M ago
8K
APTO
Promising Results from Aptose Biosciences’ TUSCANY Trial Boost Joseph Pantginis’ Buy Rating
PremiumRatings
Promising Results from Aptose Biosciences’ TUSCANY Trial Boost Joseph Pantginis’ Buy Rating
2M ago
APTO
Promising Early Results from Aptose’s TUSCANY Trial in AML Treatment
PremiumCompany AnnouncementsPromising Early Results from Aptose’s TUSCANY Trial in AML Treatment
2M ago
APTO
Aptose reports ‘promising’ early safety data from Phase 1/2 TUSCANY trial
Premium
The Fly
Aptose reports ‘promising’ early safety data from Phase 1/2 TUSCANY trial
2M ago
APTO
Aptose Biosciences Initiates TUSCANY Trial for Frontline AML Therapy
Premium
Company Announcements
Aptose Biosciences Initiates TUSCANY Trial for Frontline AML Therapy
3M ago
APTO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >